Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0001209191-21-005912

Options or other derivatives

  • Chief Commercial Officer acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

FLOWERS KIRSTEN · Chief Commercial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-01-26 Grant or award : show line 1 in the form Option to purchase common stock +125,000 $32.80 2031-01-25 125,000 125,000 D
Loading xslF345X03/doc4.xml…